nodes	percent_of_prediction	percent_of_DWPC	metapath
Morphine—OPRM1—nicotine dependence	0.784	1	CbGaD
Morphine—Drug hypersensitivity—Varenicline—nicotine dependence	0.00449	0.0311	CcSEcCtD
Morphine—Withdrawal symptom—Varenicline—nicotine dependence	0.00441	0.0306	CcSEcCtD
Morphine—Dysphoria—Varenicline—nicotine dependence	0.00418	0.029	CcSEcCtD
Morphine—Drug withdrawal syndrome—Varenicline—nicotine dependence	0.00369	0.0256	CcSEcCtD
Morphine—Balance disorder—Varenicline—nicotine dependence	0.00331	0.0229	CcSEcCtD
Morphine—Sleep disturbance—Varenicline—nicotine dependence	0.00323	0.0224	CcSEcCtD
Morphine—Intestinal obstruction—Varenicline—nicotine dependence	0.00265	0.0184	CcSEcCtD
Morphine—Nystagmus—Varenicline—nicotine dependence	0.00253	0.0176	CcSEcCtD
Morphine—CYP2C8—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00232	0.0394	CbGpPWpGaD
Morphine—Mydriasis—Varenicline—nicotine dependence	0.00227	0.0157	CcSEcCtD
Morphine—Rhinorrhoea—Varenicline—nicotine dependence	0.00223	0.0155	CcSEcCtD
Morphine—Tenderness—Varenicline—nicotine dependence	0.00207	0.0144	CcSEcCtD
Morphine—Accidental injury—Varenicline—nicotine dependence	0.00204	0.0142	CcSEcCtD
Morphine—Chest discomfort—Varenicline—nicotine dependence	0.00204	0.0142	CcSEcCtD
Morphine—Gastrooesophageal reflux disease—Varenicline—nicotine dependence	0.002	0.0139	CcSEcCtD
Morphine—Thinking abnormal—Varenicline—nicotine dependence	0.00198	0.0137	CcSEcCtD
Morphine—Lacrimation increased—Varenicline—nicotine dependence	0.00196	0.0136	CcSEcCtD
Morphine—OPRL1—Peptide GPCRs—OPRM1—nicotine dependence	0.00194	0.0329	CbGpPWpGaD
Morphine—Dysarthria—Varenicline—nicotine dependence	0.00191	0.0133	CcSEcCtD
Morphine—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00191	0.0323	CbGpPWpGaD
Morphine—Coordination abnormal—Varenicline—nicotine dependence	0.00184	0.0128	CcSEcCtD
Morphine—OPRL1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00183	0.031	CbGpPWpGaD
Morphine—Pulmonary embolism—Varenicline—nicotine dependence	0.00181	0.0125	CcSEcCtD
Morphine—Galantamine—CHRNB3—nicotine dependence	0.0018	0.141	CrCbGaD
Morphine—Abnormal dreams—Varenicline—nicotine dependence	0.00179	0.0124	CcSEcCtD
Morphine—Hypertonia—Varenicline—nicotine dependence	0.00158	0.011	CcSEcCtD
Morphine—Mental disability—Varenicline—nicotine dependence	0.00157	0.0109	CcSEcCtD
Morphine—Euphoric mood—Varenicline—nicotine dependence	0.00155	0.0108	CcSEcCtD
Morphine—Sleep disorder—Varenicline—nicotine dependence	0.00152	0.0105	CcSEcCtD
Morphine—UGT1A8—Biological oxidations—CYP2A7—nicotine dependence	0.00151	0.0256	CbGpPWpGaD
Morphine—Polyuria—Varenicline—nicotine dependence	0.00149	0.0104	CcSEcCtD
Morphine—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00149	0.0252	CbGpPWpGaD
Morphine—Disorientation—Varenicline—nicotine dependence	0.00147	0.0102	CcSEcCtD
Morphine—Eye pain—Varenicline—nicotine dependence	0.00145	0.0101	CcSEcCtD
Morphine—CYP2C8—Xenobiotics—CYP2A7—nicotine dependence	0.00144	0.0244	CbGpPWpGaD
Morphine—Injury—Varenicline—nicotine dependence	0.00143	0.00991	CcSEcCtD
Morphine—Libido decreased—Varenicline—nicotine dependence	0.00142	0.00982	CcSEcCtD
Morphine—UGT2B4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0014	0.0238	CbGpPWpGaD
Morphine—Amnesia—Varenicline—nicotine dependence	0.0014	0.00969	CcSEcCtD
Morphine—Atrial fibrillation—Varenicline—nicotine dependence	0.00139	0.00961	CcSEcCtD
Morphine—Visual disturbance—Varenicline—nicotine dependence	0.00139	0.00961	CcSEcCtD
Morphine—Thirst—Varenicline—nicotine dependence	0.00138	0.00957	CcSEcCtD
Morphine—Galantamine—CHRNA6—nicotine dependence	0.00136	0.107	CrCbGaD
Morphine—Lethargy—Varenicline—nicotine dependence	0.00134	0.00929	CcSEcCtD
Morphine—UGT2B4—Biological oxidations—CYP2A7—nicotine dependence	0.00132	0.0224	CbGpPWpGaD
Morphine—UGT2B15—Biological oxidations—CYP2A7—nicotine dependence	0.00132	0.0224	CbGpPWpGaD
Morphine—Osteoarthritis—Varenicline—nicotine dependence	0.00131	0.00911	CcSEcCtD
Morphine—UGT2B4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.0013	0.0221	CbGpPWpGaD
Morphine—Disturbance in sexual arousal—Varenicline—nicotine dependence	0.0013	0.00904	CcSEcCtD
Morphine—Affect lability—Varenicline—nicotine dependence	0.00129	0.00896	CcSEcCtD
Morphine—Psychotic disorder—Varenicline—nicotine dependence	0.00128	0.00889	CcSEcCtD
Morphine—Urinary retention—Varenicline—nicotine dependence	0.00125	0.00866	CcSEcCtD
Morphine—Mood swings—Varenicline—nicotine dependence	0.00124	0.00863	CcSEcCtD
Morphine—Liver function test abnormal—Varenicline—nicotine dependence	0.00121	0.00841	CcSEcCtD
Morphine—Dry skin—Varenicline—nicotine dependence	0.0012	0.00835	CcSEcCtD
Morphine—Abdominal pain upper—Varenicline—nicotine dependence	0.0012	0.00832	CcSEcCtD
Morphine—Hypokalaemia—Varenicline—nicotine dependence	0.00119	0.00829	CcSEcCtD
Morphine—Breast disorder—Varenicline—nicotine dependence	0.00119	0.00823	CcSEcCtD
Morphine—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00118	0.02	CbGpPWpGaD
Morphine—Cramp muscle—Varenicline—nicotine dependence	0.00118	0.0082	CcSEcCtD
Morphine—Nasopharyngitis—Varenicline—nicotine dependence	0.00117	0.00814	CcSEcCtD
Morphine—Galantamine—CHRNA5—nicotine dependence	0.00116	0.0909	CrCbGaD
Morphine—Abdominal distension—Varenicline—nicotine dependence	0.00114	0.00792	CcSEcCtD
Morphine—Dysphagia—Varenicline—nicotine dependence	0.00113	0.00787	CcSEcCtD
Morphine—OPRL1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00111	0.0188	CbGpPWpGaD
Morphine—Galantamine—CHRNA10—nicotine dependence	0.00109	0.0855	CrCbGaD
Morphine—Erectile dysfunction—Varenicline—nicotine dependence	0.00104	0.00725	CcSEcCtD
Morphine—Hyperglycaemia—Varenicline—nicotine dependence	0.00102	0.0071	CcSEcCtD
Morphine—Stomatitis—Varenicline—nicotine dependence	0.000986	0.00684	CcSEcCtD
Morphine—Conjunctivitis—Varenicline—nicotine dependence	0.000983	0.00682	CcSEcCtD
Morphine—Hepatobiliary disease—Varenicline—nicotine dependence	0.000957	0.00664	CcSEcCtD
Morphine—Bradycardia—Varenicline—nicotine dependence	0.000924	0.00641	CcSEcCtD
Morphine—OPRL1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000913	0.0155	CbGpPWpGaD
Morphine—Hypoaesthesia—Varenicline—nicotine dependence	0.000903	0.00627	CcSEcCtD
Morphine—Hallucination—Varenicline—nicotine dependence	0.000903	0.00627	CcSEcCtD
Morphine—Urinary tract disorder—Varenicline—nicotine dependence	0.000897	0.00622	CcSEcCtD
Morphine—Oedema peripheral—Varenicline—nicotine dependence	0.000895	0.00621	CcSEcCtD
Morphine—Connective tissue disorder—Varenicline—nicotine dependence	0.000892	0.00619	CcSEcCtD
Morphine—Urethral disorder—Varenicline—nicotine dependence	0.00089	0.00618	CcSEcCtD
Morphine—Visual impairment—Varenicline—nicotine dependence	0.000875	0.00607	CcSEcCtD
Morphine—OPRL1—Circadian rythm related genes—CHRNB2—nicotine dependence	0.000854	0.0145	CbGpPWpGaD
Morphine—Eye disorder—Varenicline—nicotine dependence	0.000849	0.00589	CcSEcCtD
Morphine—OPRD1—Peptide GPCRs—OPRM1—nicotine dependence	0.000829	0.0141	CbGpPWpGaD
Morphine—Angiopathy—Varenicline—nicotine dependence	0.000824	0.00572	CcSEcCtD
Morphine—Mediastinal disorder—Varenicline—nicotine dependence	0.000818	0.00568	CcSEcCtD
Morphine—Chills—Varenicline—nicotine dependence	0.000815	0.00565	CcSEcCtD
Morphine—Mental disorder—Varenicline—nicotine dependence	0.000796	0.00552	CcSEcCtD
Morphine—Malnutrition—Varenicline—nicotine dependence	0.00079	0.00548	CcSEcCtD
Morphine—Erythema—Varenicline—nicotine dependence	0.00079	0.00548	CcSEcCtD
Morphine—Galantamine—CHRNB4—nicotine dependence	0.000784	0.0614	CrCbGaD
Morphine—OPRD1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00078	0.0132	CbGpPWpGaD
Morphine—Flatulence—Varenicline—nicotine dependence	0.000779	0.0054	CcSEcCtD
Morphine—Dysgeusia—Varenicline—nicotine dependence	0.000774	0.00537	CcSEcCtD
Morphine—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.000773	0.0131	CbGpPWpGaD
Morphine—OPRL1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00077	0.0131	CbGpPWpGaD
Morphine—Back pain—Varenicline—nicotine dependence	0.000765	0.00531	CcSEcCtD
Morphine—Muscle spasms—Varenicline—nicotine dependence	0.00076	0.00527	CcSEcCtD
Morphine—UGT1A3—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000751	0.0127	CbGpPWpGaD
Morphine—Vision blurred—Varenicline—nicotine dependence	0.000745	0.00517	CcSEcCtD
Morphine—Tremor—Varenicline—nicotine dependence	0.000741	0.00514	CcSEcCtD
Morphine—Ill-defined disorder—Varenicline—nicotine dependence	0.000733	0.00509	CcSEcCtD
Morphine—Anaemia—Varenicline—nicotine dependence	0.000731	0.00507	CcSEcCtD
Morphine—OPRK1—Peptide GPCRs—OPRM1—nicotine dependence	0.000727	0.0123	CbGpPWpGaD
Morphine—Agitation—Varenicline—nicotine dependence	0.000726	0.00504	CcSEcCtD
Morphine—Galantamine—CHRNB2—nicotine dependence	0.000717	0.0562	CrCbGaD
Morphine—OPRL1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000715	0.0121	CbGpPWpGaD
Morphine—Malaise—Varenicline—nicotine dependence	0.000713	0.00495	CcSEcCtD
Morphine—Vertigo—Varenicline—nicotine dependence	0.00071	0.00493	CcSEcCtD
Morphine—Syncope—Varenicline—nicotine dependence	0.000709	0.00492	CcSEcCtD
Morphine—UGT1A3—Biological oxidations—CYP2A7—nicotine dependence	0.000708	0.012	CbGpPWpGaD
Morphine—Palpitations—Varenicline—nicotine dependence	0.000699	0.00485	CcSEcCtD
Morphine—UGT1A3—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000698	0.0118	CbGpPWpGaD
Morphine—Loss of consciousness—Varenicline—nicotine dependence	0.000695	0.00482	CcSEcCtD
Morphine—Cough—Varenicline—nicotine dependence	0.00069	0.00479	CcSEcCtD
Morphine—Convulsion—Varenicline—nicotine dependence	0.000685	0.00475	CcSEcCtD
Morphine—OPRK1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000684	0.0116	CbGpPWpGaD
Morphine—Hypertension—Varenicline—nicotine dependence	0.000682	0.00474	CcSEcCtD
Morphine—Chest pain—Varenicline—nicotine dependence	0.000673	0.00467	CcSEcCtD
Morphine—Arthralgia—Varenicline—nicotine dependence	0.000673	0.00467	CcSEcCtD
Morphine—Heroin—OPRM1—nicotine dependence	0.000673	0.0527	CrCbGaD
Morphine—Anxiety—Varenicline—nicotine dependence	0.000671	0.00465	CcSEcCtD
Morphine—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.000668	0.00464	CcSEcCtD
Morphine—Discomfort—Varenicline—nicotine dependence	0.000665	0.00461	CcSEcCtD
Morphine—Dry mouth—Varenicline—nicotine dependence	0.000658	0.00457	CcSEcCtD
Morphine—Oedema—Varenicline—nicotine dependence	0.000645	0.00448	CcSEcCtD
Morphine—Infection—Varenicline—nicotine dependence	0.000641	0.00445	CcSEcCtD
Morphine—UGT2B7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000638	0.0108	CbGpPWpGaD
Morphine—Shock—Varenicline—nicotine dependence	0.000635	0.0044	CcSEcCtD
Morphine—Nervous system disorder—Varenicline—nicotine dependence	0.000633	0.00439	CcSEcCtD
Morphine—Thrombocytopenia—Varenicline—nicotine dependence	0.000632	0.00438	CcSEcCtD
Morphine—OPRL1—Circadian rythm related genes—DRD2—nicotine dependence	0.000631	0.0107	CbGpPWpGaD
Morphine—Tachycardia—Varenicline—nicotine dependence	0.00063	0.00437	CcSEcCtD
Morphine—Skin disorder—Varenicline—nicotine dependence	0.000627	0.00435	CcSEcCtD
Morphine—OPRL1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000625	0.0106	CbGpPWpGaD
Morphine—Hyperhidrosis—Varenicline—nicotine dependence	0.000624	0.00433	CcSEcCtD
Morphine—Anorexia—Varenicline—nicotine dependence	0.000615	0.00427	CcSEcCtD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000613	0.0104	CbGpPWpGaD
Morphine—Hypotension—Varenicline—nicotine dependence	0.000603	0.00418	CcSEcCtD
Morphine—UGT2B7—Biological oxidations—CYP2A7—nicotine dependence	0.000602	0.0102	CbGpPWpGaD
Morphine—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000598	0.0101	CbGpPWpGaD
Morphine—UGT2B7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000593	0.0101	CbGpPWpGaD
Morphine—CYP2C8—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00059	0.01	CbGpPWpGaD
Morphine—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.000588	0.00408	CcSEcCtD
Morphine—Insomnia—Varenicline—nicotine dependence	0.000583	0.00405	CcSEcCtD
Morphine—OPRM1—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.000578	0.0098	CbGpPWpGaD
Morphine—Dyspnoea—Varenicline—nicotine dependence	0.000575	0.00399	CcSEcCtD
Morphine—Somnolence—Varenicline—nicotine dependence	0.000574	0.00398	CcSEcCtD
Morphine—Dyspepsia—Varenicline—nicotine dependence	0.000568	0.00394	CcSEcCtD
Morphine—OPRL1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000568	0.00963	CbGpPWpGaD
Morphine—Decreased appetite—Varenicline—nicotine dependence	0.000561	0.00389	CcSEcCtD
Morphine—OPRL1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000557	0.00944	CbGpPWpGaD
Morphine—Gastrointestinal disorder—Varenicline—nicotine dependence	0.000557	0.00386	CcSEcCtD
Morphine—Fatigue—Varenicline—nicotine dependence	0.000556	0.00386	CcSEcCtD
Morphine—Pain—Varenicline—nicotine dependence	0.000552	0.00383	CcSEcCtD
Morphine—Constipation—Varenicline—nicotine dependence	0.000552	0.00383	CcSEcCtD
Morphine—Nalbuphine—OPRM1—nicotine dependence	0.000549	0.043	CrCbGaD
Morphine—Galantamine—CHRNA3—nicotine dependence	0.000543	0.0426	CrCbGaD
Morphine—Feeling abnormal—Varenicline—nicotine dependence	0.000532	0.00369	CcSEcCtD
Morphine—Levorphanol—OPRM1—nicotine dependence	0.000528	0.0414	CrCbGaD
Morphine—Gastrointestinal pain—Varenicline—nicotine dependence	0.000528	0.00366	CcSEcCtD
Morphine—UGT1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000519	0.0088	CbGpPWpGaD
Morphine—OPRL1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000517	0.00876	CbGpPWpGaD
Morphine—Urticaria—Varenicline—nicotine dependence	0.000512	0.00356	CcSEcCtD
Morphine—Body temperature increased—Varenicline—nicotine dependence	0.00051	0.00354	CcSEcCtD
Morphine—Abdominal pain—Varenicline—nicotine dependence	0.00051	0.00354	CcSEcCtD
Morphine—Dihydrocodeine—OPRM1—nicotine dependence	0.00051	0.04	CrCbGaD
Morphine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000491	0.00832	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—FGD1—nicotine dependence	0.000491	0.00832	CbGpPWpGaD
Morphine—UGT1A1—Biological oxidations—CYP2A7—nicotine dependence	0.000489	0.00829	CbGpPWpGaD
Morphine—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000485	0.00822	CbGpPWpGaD
Morphine—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000484	0.00821	CbGpPWpGaD
Morphine—UGT1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000482	0.00818	CbGpPWpGaD
Morphine—Hypersensitivity—Varenicline—nicotine dependence	0.000475	0.0033	CcSEcCtD
Morphine—OPRD1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000472	0.00801	CbGpPWpGaD
Morphine—OPRL1—GPCR ligand binding—OPRM1—nicotine dependence	0.000466	0.00791	CbGpPWpGaD
Morphine—Asthenia—Varenicline—nicotine dependence	0.000463	0.00321	CcSEcCtD
Morphine—Pruritus—Varenicline—nicotine dependence	0.000456	0.00317	CcSEcCtD
Morphine—Naltrexone—OPRM1—nicotine dependence	0.000447	0.035	CrCbGaD
Morphine—Oxymorphone—OPRM1—nicotine dependence	0.000447	0.035	CrCbGaD
Morphine—OPRL1—Signaling by GPCR—FGD1—nicotine dependence	0.000446	0.00756	CbGpPWpGaD
Morphine—OPRL1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000443	0.00751	CbGpPWpGaD
Morphine—Diarrhoea—Varenicline—nicotine dependence	0.000441	0.00306	CcSEcCtD
Morphine—Ethylmorphine—OPRM1—nicotine dependence	0.000427	0.0335	CrCbGaD
Morphine—Dizziness—Varenicline—nicotine dependence	0.000427	0.00296	CcSEcCtD
Morphine—OPRK1—GPCR ligand binding—TAS2R16—nicotine dependence	0.000414	0.00702	CbGpPWpGaD
Morphine—Vomiting—Varenicline—nicotine dependence	0.00041	0.00285	CcSEcCtD
Morphine—Rash—Varenicline—nicotine dependence	0.000407	0.00282	CcSEcCtD
Morphine—Dermatitis—Varenicline—nicotine dependence	0.000406	0.00282	CcSEcCtD
Morphine—Headache—Varenicline—nicotine dependence	0.000404	0.0028	CcSEcCtD
Morphine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.000398	0.00675	CbGpPWpGaD
Morphine—Hydrocodone—OPRM1—nicotine dependence	0.000391	0.0306	CrCbGaD
Morphine—OPRD1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.00039	0.00661	CbGpPWpGaD
Morphine—Nausea—Varenicline—nicotine dependence	0.000383	0.00266	CcSEcCtD
Morphine—OPRM1—GPCR ligand binding—TAS2R16—nicotine dependence	0.00035	0.00594	CbGpPWpGaD
Morphine—OPRK1—Peptide ligand-binding receptors—OPRM1—nicotine dependence	0.000342	0.0058	CbGpPWpGaD
Morphine—Codeine—OPRM1—nicotine dependence	0.00034	0.0267	CrCbGaD
Morphine—OPRL1—GPCR ligand binding—DRD2—nicotine dependence	0.000337	0.00572	CbGpPWpGaD
Morphine—Galantamine—CHRNA4—nicotine dependence	0.000336	0.0263	CrCbGaD
Morphine—OPRL1—Signaling Pathways—TAS2R16—nicotine dependence	0.000335	0.00569	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000329	0.00558	CbGpPWpGaD
Morphine—Naloxone—OPRM1—nicotine dependence	0.000326	0.0256	CrCbGaD
Morphine—Hydromorphone—OPRM1—nicotine dependence	0.000324	0.0254	CrCbGaD
Morphine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.000321	0.00544	CbGpPWpGaD
Morphine—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.000317	0.00537	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000305	0.00517	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—OPRM1—nicotine dependence	0.000288	0.00489	CbGpPWpGaD
Morphine—CYP2C8—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000273	0.00463	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.000268	0.00454	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000267	0.00453	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000264	0.00447	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—FGD1—nicotine dependence	0.000263	0.00446	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000261	0.00443	CbGpPWpGaD
Morphine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00026	0.00441	CbGpPWpGaD
Morphine—UGT1A8—Metabolism—CYP2A7—nicotine dependence	0.000258	0.00438	CbGpPWpGaD
Morphine—CYP2C8—Biological oxidations—CYP2A7—nicotine dependence	0.000257	0.00437	CbGpPWpGaD
Morphine—CYP2C8—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000254	0.00431	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000242	0.00411	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—OPRM1—nicotine dependence	0.000239	0.00406	CbGpPWpGaD
Morphine—OPRD1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000238	0.00403	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000234	0.00397	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—AKR1B10—nicotine dependence	0.000232	0.00394	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000229	0.00389	CbGpPWpGaD
Morphine—UGT2B4—Metabolism—CYP2A7—nicotine dependence	0.000226	0.00383	CbGpPWpGaD
Morphine—UGT2B15—Metabolism—CYP2A7—nicotine dependence	0.000226	0.00383	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000224	0.0038	CbGpPWpGaD
Morphine—OPRD1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000221	0.00374	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—TAS2R16—nicotine dependence	0.000213	0.0036	CbGpPWpGaD
Morphine—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.000211	0.00358	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—FGD1—nicotine dependence	0.000209	0.00355	CbGpPWpGaD
Morphine—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000208	0.00354	CbGpPWpGaD
Morphine—OPRK1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000208	0.00354	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—OPRM1—nicotine dependence	0.000199	0.00338	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000198	0.00335	CbGpPWpGaD
Morphine—OPRK1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000193	0.00328	CbGpPWpGaD
Morphine—OPRL1—GPCR downstream signaling—DRD2—nicotine dependence	0.000191	0.00323	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—FGD1—nicotine dependence	0.00019	0.00323	CbGpPWpGaD
Morphine—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000189	0.00321	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—FGD1—nicotine dependence	0.000184	0.00311	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—TAS2R16—nicotine dependence	0.00018	0.00305	CbGpPWpGaD
Morphine—OPRM1—G alpha (i) signalling events—DRD2—nicotine dependence	0.000176	0.00299	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—OPRM1—nicotine dependence	0.000175	0.00296	CbGpPWpGaD
Morphine—OPRL1—Signaling by GPCR—DRD2—nicotine dependence	0.000173	0.00293	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—FGD1—nicotine dependence	0.000167	0.00283	CbGpPWpGaD
Morphine—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000166	0.00281	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—WASF2—nicotine dependence	0.000164	0.00278	CbGpPWpGaD
Morphine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000164	0.00277	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—WASF1—nicotine dependence	0.000157	0.00266	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—FGD1—nicotine dependence	0.000155	0.00263	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000147	0.00249	CbGpPWpGaD
Morphine—OPRD1—GPCR ligand binding—DRD2—nicotine dependence	0.000144	0.00244	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—TAS2R16—nicotine dependence	0.000143	0.00243	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—OPRM1—nicotine dependence	0.000141	0.0024	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—FGD1—nicotine dependence	0.000141	0.00239	CbGpPWpGaD
Morphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00014	0.00238	CbGpPWpGaD
Morphine—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000138	0.00234	CbGpPWpGaD
Morphine—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000136	0.00231	CbGpPWpGaD
Morphine—OPRK1—GPCR ligand binding—DRD2—nicotine dependence	0.000126	0.00214	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—TAS2R16—nicotine dependence	0.000126	0.00213	CbGpPWpGaD
Morphine—UGT1A3—Metabolism—CYP2A7—nicotine dependence	0.000121	0.00205	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—OPRM1—nicotine dependence	0.000113	0.00191	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—FGD1—nicotine dependence	0.000112	0.00191	CbGpPWpGaD
Morphine—OPRM1—GPCR ligand binding—DRD2—nicotine dependence	0.000107	0.00181	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—TAS2R16—nicotine dependence	0.000106	0.0018	CbGpPWpGaD
Morphine—UGT2B7—Metabolism—CYP2A7—nicotine dependence	0.000103	0.00175	CbGpPWpGaD
Morphine—OPRL1—Signaling Pathways—DRD2—nicotine dependence	0.000102	0.00173	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—OPRM1—nicotine dependence	0.000102	0.00173	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—AKR1B10—nicotine dependence	9.92e-05	0.00168	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—OPRM1—nicotine dependence	9.87e-05	0.00167	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—FGD1—nicotine dependence	9.85e-05	0.00167	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—OPRM1—nicotine dependence	8.96e-05	0.00152	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—AKR1B10—nicotine dependence	8.7e-05	0.00148	CbGpPWpGaD
Morphine—UGT1A1—Metabolism—CYP2A7—nicotine dependence	8.36e-05	0.00142	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—FGD1—nicotine dependence	8.33e-05	0.00141	CbGpPWpGaD
Morphine—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	8.19e-05	0.00139	CbGpPWpGaD
Morphine—OPRD1—GPCR downstream signaling—DRD2—nicotine dependence	8.13e-05	0.00138	CbGpPWpGaD
Morphine—OPRD1—Signaling by GPCR—DRD2—nicotine dependence	7.39e-05	0.00125	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—AKR1B10—nicotine dependence	7.35e-05	0.00125	CbGpPWpGaD
Morphine—OPRK1—GPCR downstream signaling—DRD2—nicotine dependence	7.13e-05	0.00121	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—WASF2—nicotine dependence	6.99e-05	0.00119	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—WASF1—nicotine dependence	6.7e-05	0.00114	CbGpPWpGaD
Morphine—OPRK1—Signaling by GPCR—DRD2—nicotine dependence	6.48e-05	0.0011	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—WASF2—nicotine dependence	6.13e-05	0.00104	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—OPRM1—nicotine dependence	6.04e-05	0.00102	CbGpPWpGaD
Morphine—OPRM1—GPCR downstream signaling—DRD2—nicotine dependence	6.03e-05	0.00102	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—WASF1—nicotine dependence	5.88e-05	0.000997	CbGpPWpGaD
Morphine—OPRM1—Signaling by GPCR—DRD2—nicotine dependence	5.47e-05	0.000928	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—OPRM1—nicotine dependence	5.29e-05	0.000898	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—WASF2—nicotine dependence	5.18e-05	0.000879	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—WASF1—nicotine dependence	4.97e-05	0.000842	CbGpPWpGaD
Morphine—CYP2C8—Metabolism—CYP2A7—nicotine dependence	4.4e-05	0.000747	CbGpPWpGaD
Morphine—OPRD1—Signaling Pathways—DRD2—nicotine dependence	4.36e-05	0.00074	CbGpPWpGaD
Morphine—ABCB1—Metabolism—CYP2A7—nicotine dependence	3.84e-05	0.000651	CbGpPWpGaD
Morphine—OPRK1—Signaling Pathways—DRD2—nicotine dependence	3.83e-05	0.000649	CbGpPWpGaD
Morphine—CYP2D6—Metabolism—CYP2A7—nicotine dependence	3.61e-05	0.000613	CbGpPWpGaD
Morphine—OPRM1—Signaling Pathways—DRD2—nicotine dependence	3.23e-05	0.000548	CbGpPWpGaD
Morphine—CYP3A4—Metabolism—CYP2A7—nicotine dependence	2.36e-05	0.000401	CbGpPWpGaD
